/Investor DB

Newbury Ventures — Full Portfolio

9 tracked investments · listed companies and verified rows first

Hydrocisionhydrocision.comin𝕏

HydroCision develops minimally invasive surgical instruments using proprietary FluidJet technology to selectively remove soft tissue in a precise manner.

BiotechHardwareHealthtechMedical DevicesNorth Billerica, US

PAUL KOWALSKI(Executive Officer)inRICHARD A. LYTLE, III(Executive Officer, Director)THOMAS D. ABERT(Executive Officer)inPATRICIA VANBLARCOM(Executive Officer)Rick Lytle(President & Chief Executive Officer)in

BoardLONG ZHAN(Director)

Co-investorsBioVenturesOxford Bioscience Partners

OneChronosonechronos.comin𝕏

OneChronos develops execution platforms for electronic trading using machine learning and mechanism design, serving institutional investors and traders.

AI & Machine LearningFintechMarketplacesNew York City, US

Stephen Johnson(Founder)inKelly Littlepage(Founder)inRichard Suth(Co-founder)in

PartnerBrent MacDonald· solo GP

Co-investorsAmino CapitalBoxGroupDCVC (Data Collective)Page One VenturesRising TideY Combinator+3 more

Stakedstaked.usacquired by Kraken

Staked provides a staking dashboard for reporting and running Ethereum validators, now integrated into Kraken's staking platform.

Crypto & Web3

PartnerBrent MacDonald· solo GP

Co-investorsBlockchain CoinvestorsBollinger Investment GroupDigital Currency GroupDreamers VCFabric VenturesGlobal Brain+7 more

Twelvetwelve.coin𝕏

Twelve transforms CO2 into chemicals, fuels, and materials through carbon transformation technology.

Advanced ManufacturingCleantechClimate TechHealthtechNew MaterialsMoses Lake, US

Nicholas Flanders(Founder)inEtosha Cave(Founder)inKendra Kuhl(Founder)inAndrew Cleeland(Executive Officer, Director)in

BoardMarc-Henri Galletti(Director)Nimesh Shah(Director)

PartnerBrent MacDonald· solo GP

Co-investorsBreakout VenturesDCVC (Data Collective)Dolby Family VenturesFifth WallAdvantage Partners Inc.Aera VC+36 more

Unnatural Productsunnaturalproducts.comin𝕏Sep 2019

Unnatural Products is a drug discovery platform company that develops synthetic macrocycles to target previously undruggable disease targets.

AI & Machine LearningBiotechDeep TechMedical DevicesSanta Cruz, US

Cameron Pye(Co-Founder & CEO)inJoshua Schwochert(Co-Founder & CSO)in

BoardVasudev Bailey(Director)in

PartnerBrent MacDonald· solo GP

Co-investorsAbstract VenturesArtis VenturesAsset Management CompanyBetter Ventures Central LlcBlue Bear VenturesColorcon Ventures+8 more

Other

Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.

AyarEchovoxKrakenNetCentrex

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.